董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Alfonso G. Zulueta | 男 | Director | 62 | 未披露 | 未持股 | 2025-12-05 |
| Donna M. Costello | 女 | Director | 51 | 未披露 | 未持股 | 2025-12-05 |
| Amy M. Dodrill | 女 | Director | 52 | 未披露 | 未持股 | 2025-12-05 |
| Randy L. Stone | 男 | Director | 58 | 未披露 | 未持股 | 2025-12-05 |
| Kimberly MacKay | 女 | Director | -- | 未披露 | 未持股 | 2025-12-05 |
| William S. Johnson | 男 | Director | 68 | 12.32万美元 | 未持股 | 2025-12-05 |
| Robert A. Profusek | 男 | Director | 75 | 14.32万美元 | 未持股 | 2025-12-05 |
| Kieran M. O'Sullivan | 男 | Chairman of the Board,President and Chief Executive Officer | 62 | 246.27万美元 | 未持股 | 2025-12-05 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Pratik Trivedi | 男 | Chief Operating Officer | 46 | 未披露 | 未持股 | 2025-12-05 |
| Mark Pacioni | 男 | Chief Legal & Administrative Officer and Corporate Secretary | 59 | 未披露 | 未持股 | 2025-12-05 |
| Ashish Agrawal | 男 | Vice President and Chief Financial Officer | 54 | 98.69万美元 | 未持股 | 2025-12-05 |
| Kieran M. O'Sullivan | 男 | Chairman of the Board,President and Chief Executive Officer | 62 | 246.27万美元 | 未持股 | 2025-12-05 |
董事简历
中英对照 | 中文 | 英文- Alfonso G. Zulueta
-
Alfonso G. Zulueta在三十多年中担任过各种职务，在全球制药公司礼来和公司（纽约证券交易所代码：LLY）中承担越来越大的责任，包括担任全球营销副总裁、全球肿瘤学和重症监护产品总裁，最近担任国际总裁，负责美国和加拿大以外的所有地区，从2017年到2021年底退休。Zulueta先生还曾担任公司高级职员以及礼来和公司执行委员会成员。Zulueta先生此前曾担任欧洲制药工业和协会联合会和美日商业委员会的董事会成员。Zulueta目前担任Interpharma Investments Limited董事会的非执行主席，该公司是亚洲最大的医疗保健服务集团之一Zuellig Pharma的控股公司。Zulueta先生还担任Lupin Limited（NSE：LUPIN）的董事，该公司是一家在心血管、抗糖尿病和呼吸系统领域开发和商业化广泛产品的制药公司，并且是审计和战略委员会的成员。Zulueta先生此前曾担任Glooko，Inc.、阿玛琳公司（纳斯达克股票代码：AMRN）、Syneos Health, Inc.（原纳斯达克股票代码：SYNH）和Calidi Biotherapeutics，Inc.（纽约证券交易所股票代码：CLDI）的董事。
Alfonso G. Zulueta,spent over three decades in various roles of increasing responsibility with Eli Lilly and Company (NYSE: LLY), a global pharmaceutical company, including as Vice President of Global Marketing, President of Global Oncology and Critical Care Products and, most recently, as President of International responsible for all geographies outside the United States and Canada, from 2017 until his retirement at the end of 2021. Mr. Zulueta also served as a corporate officer and a member of Eli Lilly and Company's Executive Committee. Mr. Zulueta previously served as a member of the board of the European Federation of Pharmaceutical Industries and Associations and the U.S.-Japan Business Council.Mr. Zulueta currently serves as Non-Executive Chairman of the board of directors of Interpharma Investments Limited, the holding company of Zuellig Pharma, one of the largest healthcare services groups in Asia. Mr. Zulueta also serves as a director of Lupin Limited (NSE: LUPIN), a pharmaceutical company that develops and commercializes a wide range of products in the cardiovascular, anti-diabetics, and respiratory segments, and is a member of the Audit and Strategy Committees. Mr. Zulueta previously served as a director of Glooko, Inc., Amarin Corporation (NASDAQ: AMRN), Syneos Health, Inc. (formerly, NASDAQ: SYNH) and Calidi Biotherapeutics, Inc. (NYSE: CLDI). - Alfonso G. Zulueta在三十多年中担任过各种职务，在全球制药公司礼来和公司（纽约证券交易所代码：LLY）中承担越来越大的责任，包括担任全球营销副总裁、全球肿瘤学和重症监护产品总裁，最近担任国际总裁，负责美国和加拿大以外的所有地区，从2017年到2021年底退休。Zulueta先生还曾担任公司高级职员以及礼来和公司执行委员会成员。Zulueta先生此前曾担任欧洲制药工业和协会联合会和美日商业委员会的董事会成员。Zulueta目前担任Interpharma Investments Limited董事会的非执行主席，该公司是亚洲最大的医疗保健服务集团之一Zuellig Pharma的控股公司。Zulueta先生还担任Lupin Limited（NSE：LUPIN）的董事，该公司是一家在心血管、抗糖尿病和呼吸系统领域开发和商业化广泛产品的制药公司，并且是审计和战略委员会的成员。Zulueta先生此前曾担任Glooko，Inc.、阿玛琳公司（纳斯达克股票代码：AMRN）、Syneos Health, Inc.（原纳斯达克股票代码：SYNH）和Calidi Biotherapeutics，Inc.（纽约证券交易所股票代码：CLDI）的董事。
- Alfonso G. Zulueta,spent over three decades in various roles of increasing responsibility with Eli Lilly and Company (NYSE: LLY), a global pharmaceutical company, including as Vice President of Global Marketing, President of Global Oncology and Critical Care Products and, most recently, as President of International responsible for all geographies outside the United States and Canada, from 2017 until his retirement at the end of 2021. Mr. Zulueta also served as a corporate officer and a member of Eli Lilly and Company's Executive Committee. Mr. Zulueta previously served as a member of the board of the European Federation of Pharmaceutical Industries and Associations and the U.S.-Japan Business Council.Mr. Zulueta currently serves as Non-Executive Chairman of the board of directors of Interpharma Investments Limited, the holding company of Zuellig Pharma, one of the largest healthcare services groups in Asia. Mr. Zulueta also serves as a director of Lupin Limited (NSE: LUPIN), a pharmaceutical company that develops and commercializes a wide range of products in the cardiovascular, anti-diabetics, and respiratory segments, and is a member of the Audit and Strategy Committees. Mr. Zulueta previously served as a director of Glooko, Inc., Amarin Corporation (NASDAQ: AMRN), Syneos Health, Inc. (formerly, NASDAQ: SYNH) and Calidi Biotherapeutics, Inc. (NYSE: CLDI).
- Donna M. Costello
-
Donna M. Costello，于2016年至2020年期间担任建发技术公司首席财务官，该公司是面向电信、公用事业、不间断电力供应、电缆、宽带和可再生能源市场的储能解决方案和服务的全球领导者。她曾担任Sequa公司的首席财务官（2008年至2016年）和副总裁、财务总监兼首席会计官（2002年至2008年），Sequa公司通过子公司Chromalloy是一家全球性技术公司和领先的飞机发动机和燃气轮机解决方案提供商。1995-2002年，Costello女士在Arthur Andersen，LLP.Ms担任高级经理。Costello是Rogers Corporation（NYSE：ROG）的董事会成员，该公司是一家专注于特种材料和组件的全球性公司，如弹性材料、特种有机硅和聚氨酯材料以及压敏胶带，目前担任审计委员会成员。Costello女士此前曾担任Neenah, Inc.（前身为NYSE：NP）和Horizon Global Corporation（前身为NASDAQ：HZN）的董事会成员。
Donna M. Costello,served as Chief Financial Officer of C&D Technologies, Inc., a global leader in energy storage solutions and services for the telecommunications, utility, uninterruptible power supply, cable, broadband and renewable energy markets, from 2016 to 2020. She served as Chief Financial Officer (from 2008 to 2016) and Vice President, Controller and Chief Accounting Officer (from 2002 to 2008) of Sequa Corporation, which, through its subsidiary Chromalloy, is a global technology company and a leading solutions provider for aircraft engines and gas turbines. From 1995 to 2002, Ms. Costello held the role of Senior Manager with Arthur Andersen, LLP.Ms. Costello is a member of the board of directors of Rogers Corporation (NYSE: ROG), a global company focused on specialty materials and components, such as elastomeric materials, specialty silicone and polyurethane materials and pressure sensitive tapes, and currently serves as a member of the Audit Committee. Ms. Costello previously served as a member of the board of directors of Neenah, Inc. (formerly, NYSE: NP) and Horizon Global Corporation (formerly, NASDAQ: HZN). - Donna M. Costello，于2016年至2020年期间担任建发技术公司首席财务官，该公司是面向电信、公用事业、不间断电力供应、电缆、宽带和可再生能源市场的储能解决方案和服务的全球领导者。她曾担任Sequa公司的首席财务官（2008年至2016年）和副总裁、财务总监兼首席会计官（2002年至2008年），Sequa公司通过子公司Chromalloy是一家全球性技术公司和领先的飞机发动机和燃气轮机解决方案提供商。1995-2002年，Costello女士在Arthur Andersen，LLP.Ms担任高级经理。Costello是Rogers Corporation（NYSE：ROG）的董事会成员，该公司是一家专注于特种材料和组件的全球性公司，如弹性材料、特种有机硅和聚氨酯材料以及压敏胶带，目前担任审计委员会成员。Costello女士此前曾担任Neenah, Inc.（前身为NYSE：NP）和Horizon Global Corporation（前身为NASDAQ：HZN）的董事会成员。
- Donna M. Costello,served as Chief Financial Officer of C&D Technologies, Inc., a global leader in energy storage solutions and services for the telecommunications, utility, uninterruptible power supply, cable, broadband and renewable energy markets, from 2016 to 2020. She served as Chief Financial Officer (from 2008 to 2016) and Vice President, Controller and Chief Accounting Officer (from 2002 to 2008) of Sequa Corporation, which, through its subsidiary Chromalloy, is a global technology company and a leading solutions provider for aircraft engines and gas turbines. From 1995 to 2002, Ms. Costello held the role of Senior Manager with Arthur Andersen, LLP.Ms. Costello is a member of the board of directors of Rogers Corporation (NYSE: ROG), a global company focused on specialty materials and components, such as elastomeric materials, specialty silicone and polyurethane materials and pressure sensitive tapes, and currently serves as a member of the Audit Committee. Ms. Costello previously served as a member of the board of directors of Neenah, Inc. (formerly, NYSE: NP) and Horizon Global Corporation (formerly, NASDAQ: HZN).
- Amy M. Dodrill
-
Amy M. Dodrill，曾在百特国际，Inc.（NYSE：BAX）担任全球手术解决方案和患者支持系统总裁，该公司拥有诊断、重症监护、肾脏护理、营养、医院和手术产品组合，直至2022年10月。此前，Dodrill女士曾于2012年10月至2021年12月在Hillrom Holdings，Inc.工作，该公司是一家专门从事医疗器械创新的公司，该公司被百特国际收购。在Hillrom任职期间，Dodrill女士担任过多个职位，包括全球外科总裁以及美国外科事业部副总裁兼总经理。Dodrill女士此前还曾担任Trumpf Medical Surgical Solutions NA.S.的副总裁兼总经理。Dodrill是Procept BioRobotics（NASDAQ：PRCT）的董事会成员，该公司是一家商业阶段的手术机器人公司，专注于开发泌尿外科的变革性解决方案，目前担任审计委员会和薪酬委员会的成员。
Amy M. Dodrill,served as President, Global Surgical Solutions & Patient Support Systems at Baxter International, Inc., (NYSE: BAX), a company with a portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products, until October 2022. Previously, Ms. Dodrill worked at Hillrom Holdings, Inc., a company specializing in medical device innovation, from October 2012 until December 2021 when it was acquired by Baxter International, Inc. While with Hillrom, Ms. Dodrill held various positions including President, Global Surgical and Vice President and General Manager of the U.S. Surgical Division. Ms. Dodrill also previously served as Vice President and General Manager of Trumpf Medical Surgical Solutions NA.Ms. Dodrill is a member of the board of directors of Procept BioRobotics (NASDAQ: PRCT), a commercial-stage surgical robotics company focused on developing transformative solutions in urology, and currently serves as a member of the Audit and Compensation Committees. - Amy M. Dodrill，曾在百特国际，Inc.（NYSE：BAX）担任全球手术解决方案和患者支持系统总裁，该公司拥有诊断、重症监护、肾脏护理、营养、医院和手术产品组合，直至2022年10月。此前，Dodrill女士曾于2012年10月至2021年12月在Hillrom Holdings，Inc.工作，该公司是一家专门从事医疗器械创新的公司，该公司被百特国际收购。在Hillrom任职期间，Dodrill女士担任过多个职位，包括全球外科总裁以及美国外科事业部副总裁兼总经理。Dodrill女士此前还曾担任Trumpf Medical Surgical Solutions NA.S.的副总裁兼总经理。Dodrill是Procept BioRobotics（NASDAQ：PRCT）的董事会成员，该公司是一家商业阶段的手术机器人公司，专注于开发泌尿外科的变革性解决方案，目前担任审计委员会和薪酬委员会的成员。
- Amy M. Dodrill,served as President, Global Surgical Solutions & Patient Support Systems at Baxter International, Inc., (NYSE: BAX), a company with a portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products, until October 2022. Previously, Ms. Dodrill worked at Hillrom Holdings, Inc., a company specializing in medical device innovation, from October 2012 until December 2021 when it was acquired by Baxter International, Inc. While with Hillrom, Ms. Dodrill held various positions including President, Global Surgical and Vice President and General Manager of the U.S. Surgical Division. Ms. Dodrill also previously served as Vice President and General Manager of Trumpf Medical Surgical Solutions NA.Ms. Dodrill is a member of the board of directors of Procept BioRobotics (NASDAQ: PRCT), a commercial-stage surgical robotics company focused on developing transformative solutions in urology, and currently serves as a member of the Audit and Compensation Committees.
- Randy L. Stone
-
Randy L. Stone，担任Avantor, Inc.（纽约证券交易所代码：AVTR）实验室解决方案执行副总裁，该公司是一家为生物制药和医疗保健、教育以及政府和先进技术行业的客户提供关键任务产品和服务的全球领先供应商，任期至2024年7月。Avantor实验室解决方案部门是一项价值数十亿美元的业务，其中包括全面的产品、服务和数字解决方案组合，以实现对生命科学研究、诊断和质量控制工作流程的洞察力，并支持Avantor自己的研发计划。Stone先生于2023年4月加入Avantor，担任专研产品和材料执行副总裁。在加入Avantor之前，Stone先生曾担任杜邦公司（NYSE：DD）移动和材料部门的总裁，该部门是一家领先的工程聚合物、性能树脂和先进解决方案供应商，服务于电子、工业、消费和运输市场，从2016年到2022年11月，杜邦公司剥离了大部分业务。从2012年到2015年，Stone先生担任杜邦公司投资者关系总监，在此期间，他获得了与机构投资者和分析师互动的丰富经验。在此之前，Stone先生曾担任杜邦亚洲区域总监，常驻中国上海。
Randy L. Stone,served as Executive Vice President of Laboratory Solutions for Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma and healthcare, education and government and advanced technologies industries, until July 2024. Avantor's Laboratory Solutions segment is a multi-billion-dollar business that includes a comprehensive portfolio of products, services and digital solutions to enable insights in life sciences research, diagnostic and quality control workflows and supports Avantor's own research and development initiatives. Mr. Stone joined Avantor in April 2023 as Executive Vice President, Proprietary Research Products and Materials. Prior to joining Avantor, Mr. Stone served as the President of DuPont's (NYSE: DD) Mobility and Materials segment, a leading provider of engineered polymers, performance resins and advanced solutions serving the electronics, industrial, consumer and transportation markets, from 2016 until November 2022 when DuPont divested the majority of the business. From 2012 until 2015, Mr. Stone served as a Director of Investor Relations for DuPont, during which time he gained extensive experience interacting with institutional investors and analysts. Prior to that, Mr. Stone served as a DuPont Regional Director in Asia, based in Shanghai, China. - Randy L. Stone，担任Avantor, Inc.（纽约证券交易所代码：AVTR）实验室解决方案执行副总裁，该公司是一家为生物制药和医疗保健、教育以及政府和先进技术行业的客户提供关键任务产品和服务的全球领先供应商，任期至2024年7月。Avantor实验室解决方案部门是一项价值数十亿美元的业务，其中包括全面的产品、服务和数字解决方案组合，以实现对生命科学研究、诊断和质量控制工作流程的洞察力，并支持Avantor自己的研发计划。Stone先生于2023年4月加入Avantor，担任专研产品和材料执行副总裁。在加入Avantor之前，Stone先生曾担任杜邦公司（NYSE：DD）移动和材料部门的总裁，该部门是一家领先的工程聚合物、性能树脂和先进解决方案供应商，服务于电子、工业、消费和运输市场，从2016年到2022年11月，杜邦公司剥离了大部分业务。从2012年到2015年，Stone先生担任杜邦公司投资者关系总监，在此期间，他获得了与机构投资者和分析师互动的丰富经验。在此之前，Stone先生曾担任杜邦亚洲区域总监，常驻中国上海。
- Randy L. Stone,served as Executive Vice President of Laboratory Solutions for Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the biopharma and healthcare, education and government and advanced technologies industries, until July 2024. Avantor's Laboratory Solutions segment is a multi-billion-dollar business that includes a comprehensive portfolio of products, services and digital solutions to enable insights in life sciences research, diagnostic and quality control workflows and supports Avantor's own research and development initiatives. Mr. Stone joined Avantor in April 2023 as Executive Vice President, Proprietary Research Products and Materials. Prior to joining Avantor, Mr. Stone served as the President of DuPont's (NYSE: DD) Mobility and Materials segment, a leading provider of engineered polymers, performance resins and advanced solutions serving the electronics, industrial, consumer and transportation markets, from 2016 until November 2022 when DuPont divested the majority of the business. From 2012 until 2015, Mr. Stone served as a Director of Investor Relations for DuPont, during which time he gained extensive experience interacting with institutional investors and analysts. Prior to that, Mr. Stone served as a DuPont Regional Director in Asia, based in Shanghai, China.
- Kimberly MacKay
-
Kimberly MacKay，担任West Pharmaceutical Services, Inc.高级副总裁、总法律顾问和公司秘书。MacKay女士还是新泽西州社区基金会的董事会成员，以及BAYADA家庭保健的合规、审计和风险委员会。作为非雇员董事，MacKay女士将以与公司其他非雇员董事相同的方式获得补偿，这些补偿是公司先前在其于2025年3月28日向美国证券交易委员会提交的关于附表14A的最终代理声明中披露的。MacKay女士将担任董事会提名、治理和可持续发展委员会以及技术和交易委员会的成员。
Kimberly MacKay,serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. Ms. MacKay is also a member of the Board of the Community Foundation of New Jersey, and the Compliance, Audit and Risk Committee for BAYADA Home Health Care. As a non-employee director, Ms. MacKay will receive compensation in the same manner as the Company's other non-employee directors, which compensation the Company previously disclosed in its Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on March 28, 2025. Ms. MacKay will serve as a member of the Nominating, Governance and Sustainability Committee and Technology and Transactions Committee of the Board. - Kimberly MacKay，担任West Pharmaceutical Services, Inc.高级副总裁、总法律顾问和公司秘书。MacKay女士还是新泽西州社区基金会的董事会成员，以及BAYADA家庭保健的合规、审计和风险委员会。作为非雇员董事，MacKay女士将以与公司其他非雇员董事相同的方式获得补偿，这些补偿是公司先前在其于2025年3月28日向美国证券交易委员会提交的关于附表14A的最终代理声明中披露的。MacKay女士将担任董事会提名、治理和可持续发展委员会以及技术和交易委员会的成员。
- Kimberly MacKay,serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. Ms. MacKay is also a member of the Board of the Community Foundation of New Jersey, and the Compliance, Audit and Risk Committee for BAYADA Home Health Care. As a non-employee director, Ms. MacKay will receive compensation in the same manner as the Company's other non-employee directors, which compensation the Company previously disclosed in its Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on March 28, 2025. Ms. MacKay will serve as a member of the Nominating, Governance and Sustainability Committee and Technology and Transactions Committee of the Board.
- William S. Johnson
-
William S. Johnson，他曾担任Cabot Microelectronics Corporation（前身为纳斯达克股票代码：CCMP）的首席财务官近15年，首先担任副总裁（2003年4月至2013年4月），然后担任执行副总裁（直到2018年1月）。Johnson先生于2018年1月至2019年1月担任首席执行官高级顾问。Cabot Microelectronics Corporation，后来被称为CMC材料公司，现在是Entegris, Inc. （纳斯达克股票代码：ENTG）的全资子公司，是一家主要为半导体行业提供先进材料的领先供应商。从2000年8月到2003年3月，他担任Budget Group， Inc.（前纽约证券交易所代码：BD）的执行副总裁兼首席财务官，该公司是全球公认的汽车租赁公司，现在是Avis Budget Group（纳斯达克代码：car）的一部分。从1983年到1999年，Johnson先生在BP Amoco（纽约证券交易所代码：BP）（全球石油、天然气和化学公司）担任各种财务和管理职务。Johnson目前担任Waldom Electronics（电子和电气元件的主要分销商）的顾问委员会成员。
William S. Johnson,served as Chief Financial Officer of Cabot Microelectronics Corporation (formerly NASDAQ: CCMP) for almost fifteen years, first as Vice President, from April 2003 until April 2013, and then as Executive Vice President, until January 2018. Mr. Johnson served as Senior Advisor to the Chief Executive Officer from January 2018 until January 2019. Cabot Microelectronics Corporation, later known as CMC Materials, Inc., and now a wholly owned subsidiary of Entegris, Inc. (NASDAQ: ENTG), is a leading supplier of advanced materials primarily for the semiconductor industry. From August 2000 until March 2003, Mr. Johnson served as Executive Vice President and Chief Financial Officer of Budget Group, Inc. (formerly NYSE: BD), the globally recognized car rental company, now a part of the Avis Budget Group (NASDAQ: CAR). From 1983 to 1999, Mr. Johnson served in various finance and management roles of increasing responsibility with BP Amoco (NYSE: BP), the global oil, gas and chemical company.Mr. Johnson currently serves as a member of the advisory board of Waldom Electronics, a master distributor of electronic and electrical components. - William S. Johnson，他曾担任Cabot Microelectronics Corporation（前身为纳斯达克股票代码：CCMP）的首席财务官近15年，首先担任副总裁（2003年4月至2013年4月），然后担任执行副总裁（直到2018年1月）。Johnson先生于2018年1月至2019年1月担任首席执行官高级顾问。Cabot Microelectronics Corporation，后来被称为CMC材料公司，现在是Entegris, Inc. （纳斯达克股票代码：ENTG）的全资子公司，是一家主要为半导体行业提供先进材料的领先供应商。从2000年8月到2003年3月，他担任Budget Group， Inc.（前纽约证券交易所代码：BD）的执行副总裁兼首席财务官，该公司是全球公认的汽车租赁公司，现在是Avis Budget Group（纳斯达克代码：car）的一部分。从1983年到1999年，Johnson先生在BP Amoco（纽约证券交易所代码：BP）（全球石油、天然气和化学公司）担任各种财务和管理职务。Johnson目前担任Waldom Electronics（电子和电气元件的主要分销商）的顾问委员会成员。
- William S. Johnson,served as Chief Financial Officer of Cabot Microelectronics Corporation (formerly NASDAQ: CCMP) for almost fifteen years, first as Vice President, from April 2003 until April 2013, and then as Executive Vice President, until January 2018. Mr. Johnson served as Senior Advisor to the Chief Executive Officer from January 2018 until January 2019. Cabot Microelectronics Corporation, later known as CMC Materials, Inc., and now a wholly owned subsidiary of Entegris, Inc. (NASDAQ: ENTG), is a leading supplier of advanced materials primarily for the semiconductor industry. From August 2000 until March 2003, Mr. Johnson served as Executive Vice President and Chief Financial Officer of Budget Group, Inc. (formerly NYSE: BD), the globally recognized car rental company, now a part of the Avis Budget Group (NASDAQ: CAR). From 1983 to 1999, Mr. Johnson served in various finance and management roles of increasing responsibility with BP Amoco (NYSE: BP), the global oil, gas and chemical company.Mr. Johnson currently serves as a member of the advisory board of Waldom Electronics, a master distributor of electronic and electrical components.
- Robert A. Profusek
-
Robert A. Profusek是琼斯天并购的负责人，他在1975年加入这家全球性律师事务所。他也是瓦莱罗能源公司的首席董事，并是该公司的薪酬委员会及提名委员及治理委员会委员。此前，他曾担任另外两个纽约证券交易所上市公司的董事。
Robert A. Profusek,is a partner with Jones Day, a leading global law firm, where he serves as the Chair of the Global Mergers and Acquisitions practice. Since joining Jones Day in 1975, Mr. Profusek has been recognized as one of the world's leading mergers and acquisitions and corporate governance lawyers. He has worked on hundreds of mergers, acquisitions and buyouts and has advised many boards and director committees on sensitive governance matters.Since 2005, Mr. Profusek has been a member of the board of directors of Valero Energy Corporation (NYSE: VLO), the largest independent petroleum refiner in the world and the world's second largest renewable fuels producer, currently serving as Lead Independent Director and as a member of the Human Resources and Compensation Committee. Mr. Profusek is also a member of the board of directors of Kodiak Sciences, Inc., (NASDAQ: KOD), a biopharmaceutical company specializing in therapeutics to treat chronic, high-prevalence ophthalmic diseases, and currently serves as Lead Independent Director, Chair of the Nominating and Corporate Governance Committee and as a member of the Compensation Committee. He previously served as a director of two other publicly traded companies that were acquired. - Robert A. Profusek是琼斯天并购的负责人，他在1975年加入这家全球性律师事务所。他也是瓦莱罗能源公司的首席董事，并是该公司的薪酬委员会及提名委员及治理委员会委员。此前，他曾担任另外两个纽约证券交易所上市公司的董事。
- Robert A. Profusek,is a partner with Jones Day, a leading global law firm, where he serves as the Chair of the Global Mergers and Acquisitions practice. Since joining Jones Day in 1975, Mr. Profusek has been recognized as one of the world's leading mergers and acquisitions and corporate governance lawyers. He has worked on hundreds of mergers, acquisitions and buyouts and has advised many boards and director committees on sensitive governance matters.Since 2005, Mr. Profusek has been a member of the board of directors of Valero Energy Corporation (NYSE: VLO), the largest independent petroleum refiner in the world and the world's second largest renewable fuels producer, currently serving as Lead Independent Director and as a member of the Human Resources and Compensation Committee. Mr. Profusek is also a member of the board of directors of Kodiak Sciences, Inc., (NASDAQ: KOD), a biopharmaceutical company specializing in therapeutics to treat chronic, high-prevalence ophthalmic diseases, and currently serves as Lead Independent Director, Chair of the Nominating and Corporate Governance Committee and as a member of the Compensation Committee. He previously served as a director of two other publicly traded companies that were acquired.
- Kieran M. O'Sullivan
-
Kieran M. O'Sullivan是CTS公司的总裁以及首席执行官。在2013年1月7日担任现有职务外，O'Sullivan担任洲际AG集团全球娱乐信息节目和链接业务的执行副总裁，同时领导北美自由贸易协定的内部部门，他在2006年加入洲际AG集团，该公司是一家全球汽车提供商。
Kieran M. O'Sullivan,joined CTS in January 2013 as President and Chief Executive Officer and was appointed Chairman of the Board in May 2014. From 2006 until 2012, Mr. O'Sullivan served in several executive-level roles with Continental A.G., a global business focused on technology solutions and products for the transportation and mobility industries, first serving as Executive Vice President of the Global Infotainment and Connectivity business and later adding responsibility for its NAFTA Interior Division. From 2004 until 2006, Mr. O'Sullivan served as Corporate Vice President of Motorola's Automotive business.Since 2015, Mr. O'Sullivan has been a member of the board of directors of LCI Industries (NYSE: LCII), a supplier of engineered components for manufacturers of recreational vehicles, manufactured homes, marine applications and for related aftermarkets, and currently serves as Chair of the Risk Committee and as a member of the Audit and Corporate Governance, Nominating and Sustainability Committees. - Kieran M. O'Sullivan是CTS公司的总裁以及首席执行官。在2013年1月7日担任现有职务外，O'Sullivan担任洲际AG集团全球娱乐信息节目和链接业务的执行副总裁，同时领导北美自由贸易协定的内部部门，他在2006年加入洲际AG集团，该公司是一家全球汽车提供商。
- Kieran M. O'Sullivan,joined CTS in January 2013 as President and Chief Executive Officer and was appointed Chairman of the Board in May 2014. From 2006 until 2012, Mr. O'Sullivan served in several executive-level roles with Continental A.G., a global business focused on technology solutions and products for the transportation and mobility industries, first serving as Executive Vice President of the Global Infotainment and Connectivity business and later adding responsibility for its NAFTA Interior Division. From 2004 until 2006, Mr. O'Sullivan served as Corporate Vice President of Motorola's Automotive business.Since 2015, Mr. O'Sullivan has been a member of the board of directors of LCI Industries (NYSE: LCII), a supplier of engineered components for manufacturers of recreational vehicles, manufactured homes, marine applications and for related aftermarkets, and currently serves as Chair of the Risk Committee and as a member of the Audit and Corporate Governance, Nominating and Sustainability Committees.
高管简历
中英对照 | 中文 | 英文- Pratik Trivedi
Pratik Trivedi，高级副总裁。Trivedi先生于2024年4月29日加入CTS。就在加入CTS之前，Trivedi先生自2017年起担任全球电源管理公司伊顿 PLC移动业务北美区副总裁。在担任该职务之前，Trivedi先生曾在康明斯公司担任多个关键职务。
Pratik Trivedi,Senior Vice President. Mr. Trivedi joined CTS on April 29, 2024. Immediately prior to joining CTS, Mr. Trivedi served as Vice President, North America for the mobility business of Eaton Corporation plc, a global power management company, since 2017. Prior to that role, Mr. Trivedi served in several key roles with Cummins, Inc..- Pratik Trivedi，高级副总裁。Trivedi先生于2024年4月29日加入CTS。就在加入CTS之前，Trivedi先生自2017年起担任全球电源管理公司伊顿 PLC移动业务北美区副总裁。在担任该职务之前，Trivedi先生曾在康明斯公司担任多个关键职务。
- Pratik Trivedi,Senior Vice President. Mr. Trivedi joined CTS on April 29, 2024. Immediately prior to joining CTS, Mr. Trivedi served as Vice President, North America for the mobility business of Eaton Corporation plc, a global power management company, since 2017. Prior to that role, Mr. Trivedi served in several key roles with Cummins, Inc..
- Mark Pacioni
Mark Pacioni，拥有超过30年的法律经验，最近于2019年4月至2025年6月担任CareerBuilder，LLC及其后续公司CareerBuilder + Monster的首席法务官和秘书，该公司是一家全球性的端到端人力资本解决方案公司。在此之前，Pacioni先生曾在诺尔斯公司、Molex，Inc.和波音公司担任高级法律职务。在加入波音公司之前，Pacioni先生在代表上市公司处理交易和治理事务的私人执业中，还曾担任美国证券交易委员会的特别顾问。Pacioni先生拥有乔治城大学法学院法学博士学位和乔治城大学国际关系学士学位。
Mark Pacioni,has over 30 years of legal experience, and most recently from April 2019 to June 2025 served as Chief Legal Officer and Secretary of CareerBuilder, LLC and its successor company, CareerBuilder + Monster, a global, end-to-end human capital solutions company. Prior to that Mr. Pacioni held senior legal roles at Knowles Corp., Molex, Inc., and the Boeing Co. Prior to Boeing, Mr. Pacioni was in private practice representing public companies on transactions and governance matters and also served as Special Counsel at the U.S. Securities and Exchange Commission. Mr. Pacioni holds a J.D. degree from Georgetown University School of Law and B.A. in International Relations from Georgetown University.- Mark Pacioni，拥有超过30年的法律经验，最近于2019年4月至2025年6月担任CareerBuilder，LLC及其后续公司CareerBuilder + Monster的首席法务官和秘书，该公司是一家全球性的端到端人力资本解决方案公司。在此之前，Pacioni先生曾在诺尔斯公司、Molex，Inc.和波音公司担任高级法律职务。在加入波音公司之前，Pacioni先生在代表上市公司处理交易和治理事务的私人执业中，还曾担任美国证券交易委员会的特别顾问。Pacioni先生拥有乔治城大学法学院法学博士学位和乔治城大学国际关系学士学位。
- Mark Pacioni,has over 30 years of legal experience, and most recently from April 2019 to June 2025 served as Chief Legal Officer and Secretary of CareerBuilder, LLC and its successor company, CareerBuilder + Monster, a global, end-to-end human capital solutions company. Prior to that Mr. Pacioni held senior legal roles at Knowles Corp., Molex, Inc., and the Boeing Co. Prior to Boeing, Mr. Pacioni was in private practice representing public companies on transactions and governance matters and also served as Special Counsel at the U.S. Securities and Exchange Commission. Mr. Pacioni holds a J.D. degree from Georgetown University School of Law and B.A. in International Relations from Georgetown University.
- Ashish Agrawal
Ashish Agrawal，副总裁兼首席财务官。2013年11月11日，他被选为CTS副总裁兼首席财务官。他于2011年6月加入CTS，担任财务和企业发展副总裁，并于2011年9月1日当选为财务主管。在加入CTS之前，他于2007年开始在Dometic Group AB（冰箱、遮阳篷和空调制造商）担任美洲高级副总裁兼首席财务官。在此之前，他从1994年12月开始在通用电气公司担任各种职务。
Ashish Agrawal,Vice President and Chief Financial Officer. On November 11, 2013, Mr. Agrawal was elected Vice President and Chief Financial Officer of CTS. Mr. Agrawal joined CTS in June 2011 as Vice President, Treasury and Corporate Development, and was elected as Treasurer on September 1, 2011. Before joining CTS, Mr. Agrawal was with Dometic Group AB, a manufacturer of refrigerators, awnings and air conditioners, as Senior Vice President and Chief Financial Officer, Americas, beginning in 2007. Prior to that, Mr. Agrawal was with General Electric Company in various positions beginning in December 1994.- Ashish Agrawal，副总裁兼首席财务官。2013年11月11日，他被选为CTS副总裁兼首席财务官。他于2011年6月加入CTS，担任财务和企业发展副总裁，并于2011年9月1日当选为财务主管。在加入CTS之前，他于2007年开始在Dometic Group AB（冰箱、遮阳篷和空调制造商）担任美洲高级副总裁兼首席财务官。在此之前，他从1994年12月开始在通用电气公司担任各种职务。
- Ashish Agrawal,Vice President and Chief Financial Officer. On November 11, 2013, Mr. Agrawal was elected Vice President and Chief Financial Officer of CTS. Mr. Agrawal joined CTS in June 2011 as Vice President, Treasury and Corporate Development, and was elected as Treasurer on September 1, 2011. Before joining CTS, Mr. Agrawal was with Dometic Group AB, a manufacturer of refrigerators, awnings and air conditioners, as Senior Vice President and Chief Financial Officer, Americas, beginning in 2007. Prior to that, Mr. Agrawal was with General Electric Company in various positions beginning in December 1994.
- Kieran M. O'Sullivan
Kieran M. O'Sullivan是CTS公司的总裁以及首席执行官。在2013年1月7日担任现有职务外，O'Sullivan担任洲际AG集团全球娱乐信息节目和链接业务的执行副总裁，同时领导北美自由贸易协定的内部部门，他在2006年加入洲际AG集团，该公司是一家全球汽车提供商。
Kieran M. O'Sullivan,joined CTS in January 2013 as President and Chief Executive Officer and was appointed Chairman of the Board in May 2014. From 2006 until 2012, Mr. O'Sullivan served in several executive-level roles with Continental A.G., a global business focused on technology solutions and products for the transportation and mobility industries, first serving as Executive Vice President of the Global Infotainment and Connectivity business and later adding responsibility for its NAFTA Interior Division. From 2004 until 2006, Mr. O'Sullivan served as Corporate Vice President of Motorola's Automotive business.Since 2015, Mr. O'Sullivan has been a member of the board of directors of LCI Industries (NYSE: LCII), a supplier of engineered components for manufacturers of recreational vehicles, manufactured homes, marine applications and for related aftermarkets, and currently serves as Chair of the Risk Committee and as a member of the Audit and Corporate Governance, Nominating and Sustainability Committees.- Kieran M. O'Sullivan是CTS公司的总裁以及首席执行官。在2013年1月7日担任现有职务外，O'Sullivan担任洲际AG集团全球娱乐信息节目和链接业务的执行副总裁，同时领导北美自由贸易协定的内部部门，他在2006年加入洲际AG集团，该公司是一家全球汽车提供商。
- Kieran M. O'Sullivan,joined CTS in January 2013 as President and Chief Executive Officer and was appointed Chairman of the Board in May 2014. From 2006 until 2012, Mr. O'Sullivan served in several executive-level roles with Continental A.G., a global business focused on technology solutions and products for the transportation and mobility industries, first serving as Executive Vice President of the Global Infotainment and Connectivity business and later adding responsibility for its NAFTA Interior Division. From 2004 until 2006, Mr. O'Sullivan served as Corporate Vice President of Motorola's Automotive business.Since 2015, Mr. O'Sullivan has been a member of the board of directors of LCI Industries (NYSE: LCII), a supplier of engineered components for manufacturers of recreational vehicles, manufactured homes, marine applications and for related aftermarkets, and currently serves as Chair of the Risk Committee and as a member of the Audit and Corporate Governance, Nominating and Sustainability Committees.